Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1624, 2008-01, pp. : 11-11
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Anti-TNF therapy: which variables affect cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 546, 2008-01 ,pp. :
Access to resources
Recommend
Menopausal hormone therapy: lower fracture risk, but at a cost?
Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. :
n-3 PUFA post-MI: worth the cost?
Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. :
Epoetin- in heart surgery patients - not worth the cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 283, 2000-01 ,pp. :
Newer drugs for rheumatoid arthritis worth their cost?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 338, 2001-01 ,pp. :